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A number of animal models have been developed to
investigate calcium oxalate (CaOx) nephrolithiasis. Ethylene
glycol (EG)-induced hyperoxaluria in rats is most common,
but is criticized because EG and some of its metabolites are
nephrotoxic and EG causes metabolic acidosis. Both oxalate
(Ox) and CaOx crystals are also injurious to renal epithelial
cells. Thus, it is difficult to distinguish the effects of EG and its
metabolites from those induced by Ox and CaOx crystals.
This study was performed to investigate hydroxy-L-proline
(HLP), a common ingredient of many diets, as a
hyperoxaluria-inducing agent. In rats, HLP has been shown to
induce CaOx nephrolithiasis in only hypercalciuric conditions.
Five percent HLP mixed with chow was given to male
Sprague–Dawley rats for 63 days, resulting in hyperoxaluria,
CaOx crystalluria, and nephrolithiasis. Crystal deposits were
surrounded by ED-1-positive inflammatory cells. Cell injury
and death was followed by regeneration, as suggested by an
increase in proliferating cell nuclear antigen-positive cells.
Both osteopontin (OPN) and CD44 were upregulated.
Staining for CD44 and OPN was intense in cells lining the
tubules that contained crystals. Along with a rise in urinary
Ox and lactate dehydrogenase, there were significant
increases in 8-isoprostane and hydrogen peroxide excretion,
indicating that the oxidative stress induced cell injury. Thus,
HLP-induced hyperoxaluria alone can induce CaOx
nephrolithiasis in rats.
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Increased urinary excretion of oxalate (Ox) or hyperoxaluria
is the result of either genetic (primary hyperoxaluria) or
environmental factors (secondary hyperoxaluria). Enhanced
absorption of Ox, secondary to many gastrointestinal
diseases, ileal resection, or jejuno-ileal bypass, is called
enteric hyperoxaluria.1,2 Hyperoxaluria can result in uro-
lithiasis, nephrocalcinosis, metabolic acidosis, hematuria,
pyelonephritis, hydronephrosis, and renal failure. In the case
of primary hyperoxaluria, however, there is a systemic
deposition of calcium oxalate (CaOx) in almost all of the
body tissues including kidneys, heart, bone, cartilage, teeth,
vasculature, and brain.3 Patients with primary hyperoxaluria
eventually develop end-stage renal failure, usually in child-
hood. Patients with enteric hyperoxaluria may also develop
inflammation and end-stage renal disease.
Several animal models have been developed to investigate
hyperoxaluria and its consequences.4 In the most common
model, ethylene glycol (EG), a precursor of Ox, is given to
rats in their drinking water5,6 with or without additional
ammonium chloride or vitamin D. Animals develop hyper-
oxaluria, which leads to crystalluria and CaOx crystal depo-
sition in the kidneys.4–6 Hyperoxaluria and crystal deposition
are associated with lipid peroxidation and injury to the renal
epithelium,7–9 and altered expression of various genes and
production of macromolecules10–20 including bikunin, a-1-
microglobulin, Tamm–Horsfall protein, osteopontin (OPN),
and haparan sulfate. However, EG consumption leads
to multiorgan injuries and concentrations above 0.75%
may produce metabolic acidosis.21–23 In addition, in the
EG model, Ox may not be the only cause of injury and
inflammation. Many other metabolites of EG are shown to
be injurious to the renal epithelium.24
In response to various criticisms of the EG model, we
decided to induce hyperoxaluria by the oral administration of
hydroxy-L-proline (HLP), a physiological precursor of Ox.
HLP is a derivative of the common amino acid proline and a
component of collagen, thus a common ingredient of many
Western diets. We treated rats with 5.2% (w/v) HLP for
10 days, which produced hyperoxaluria; however, the treat-
ment did not result in nephrolithiasis, the deposition of
CaOx crystals in the kidney.9 The addition of 10% HLP to
the standard diet of pigs resulted in hyperoxaluria, CaOx
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crystalluria, and nephrolithiasis at 20 days.25 Administration
of 3 or 5% HLP in drinking water to genetic hypercalciuric
(GH) rats for 18 weeks produced CaOx crystal deposits in
their urinary space.26 GH rats generate stones of poorly
crystalline calcium phosphate (CaP) in their kidneys and
ureters. It was concluded that hypercalciuria and CaP crystal
deposition played a significant role in the development
of CaOx nephrolithiasis in these rats. We report here that the
addition of 5% HLP to regular chow not only induces
hyperoxaluria and crystalluria, but also promotes the
formation of CaOx crystal deposits in the rat kidneys
without additional hypercalciuria and CaP crystal depo-
sition. Morphological changes induced by HLP adminis-
tration and CaOx crystal deposition are similar to those
seen in other animal hyperoxaluria models of CaOx
nephrolithiasis.
RESULTS
All rats stayed healthy and gained weight. However, over
time, the treated rats gained significantly less weight (Po0.5)
compared to the normal controls, even though both consu-
med similar amounts of food (Figure 1a and d). Treated rats
drank significantly (Po0.005) more water (Figure 1b) than
the controls and also produced significantly more (Po0.02)
urine (Figure 1c). Creatinine levels were significantly lower
in the urine of the treated rats (Figure 2a). They also
demonstrated significantly lower creatinine clearance (Figure
2b). Although the pH of treated rat urine was generally
lower than that of the controls (results not shown), the
differences were not significant.
Urinary ions and enzymes
We determined the urinary excretion of calcium (Ca) and Ox
ions, as they have been shown to be directly involved in CaOx
supersaturation and crystallization. They have also been
shown to be altered during experimental induction of hyper-
oxaluria and CaOx nephrolithiasis in male rats. Compared to
baseline, urinary Ox excretion increased significantly in
treated rats (Figure 3a), reaching the highest level by day 14.
It remained considerably higher than control levels for all
time periods investigated from day 7 to 63. Excretion of Ox
by the control rats remained at the baseline level. On the
other hand, the urinary excretion of Ca by the treated rats
decreased significantly compared to the baseline and was
significantly lower than the urinary excretion of Ca by the
controls rats for all time periods investigated (Figure 3b).
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Figure 1 | Food intake by the rats (g/day). (a) Compared to baseline food intake on day 0, all rats consumed significantly more food on all
other days. Treated rats, however, ate less than the control rats. (b) Rats on HLP drank significantly more water than the control rats whose
water consumption did not differ significantly from the baseline. (c) Rats on HLP excreted more urine than the control rats whose urinary
excretion did not differ from the baseline. (d) Both control and treated rats gained significant weight compared to day 0, but treated rats
gained significantly less weight compared to the controls.
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Ca excretion decreased precipitously within the first 2 weeks
and continued to decrease thereafter, but not as significantly.
There was a significant increase in lactate dehydrogenase
(LDH) in the urine of treated rats compared to the baseline
level, and it remained significantly high compared to controls
for all time periods studied (Figure 4a). Administration of
HLP was also associated with a significant increase in urinary
hydrogen peroxide (H2O2) and 8-isoprostanec (8-IP) (Figure
4b and c). There was a significant increase in urinary H2O2
and 8-IP by day 7, which continued to increase till day 28.
After day 28, there was a gradual but significant drop in their
urinary concentration; however, the urinary concentration of
both H2O2 and 8-IP stayed significantly higher than the
baseline and control levels.
Crystalluria
Microscopic analysis revealed that the urine of control rats
was either devoid of any crystals or had CaP- and/or struvite-
type crystals (Table 1). By day 7, all treated rats produced a
large number of CaOx dihydrate (COD) and a few CaOx
monohydrate (COM) crystals along with a few struvite and
CaP crystals. Struvite crystals had the typical coffin-shaped
habit and CaP crystals were generally spherulitic (Figure 5a).
COD crystals had the typical bipyramidal habit, whereas
COM crystals were plate-like, often with characteristic
dumbbell-shaped morphology (Figure 5b). By day 14, the
number of COM and COD crystals in the urine increased,
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Figure 2 | Urinary creatinine and creatinine clearance. (a) Treated
rats had significantly less creatinine in their urine. (b) Treated rats
demonstrated significantly less creatinine clearance than the control
rats.
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Figure 3 | Urinary excretion of calcium and Ox. (a) There was
significant increase in urinary Ox in the urine of treated rats, reaching
highest levels by day 14. Urinary Ox of controls rats remained at the
baseline level. (b) Calcium excretion decreased significantly over
time, compared to both the control and baseline levels.
Table 1 | Crystalluria type and score on various days
Day Control Treated
0 Str 1, CaP 0–1 Str 1, CaP 0–1
7 Str 1, CaP 0–1 Str 1, CaP 0–1, COM 1, COD 3
14 Str 1, CaP 0–1 Str 1, CaP 0–1, COM 3, COD 3
21 Str 1, CaP 0–1 Str 1, CaP 0–1, COM 3, COD 2
28 Str 1, CaP 0–1 Str 1, CaP 0–1, COM 1–3, COD 1-2
35 Str 1, CaP 0–1 Str 1, CaP 0–1, COM 1–3, COD 1–2
42 Str 1, CaP 0–1 Str 1, CaP 0–1, COM 1–3, COD 1–2
49 Str 1, CaP 0–1 Str 0–1, CaP 0–1, COM 1–3, COD 1–2
56 Str 1, CaP 0–1 Str 0–1, CaP 0–1, COM 1–3, COD 1–2
63 Str 1, CaP 0–1 Str 0–1, CaP 0–1, COM 1–3, COD 1–2
CaP, calcium phosphate; COD, calcium oxalate dihydrate; COM, calcium oxalate
monohydrate; Str, struvite-type crystals.
Drop of urine was mounted on a glass slide and examined by a light microscopy at
 10. Five fields/urine sample were examined and average recorded as 0=no
crystals, 1=up to 10 crystal/field, 2=10–20 crystals/field, and 3=more than 20 crystals.
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whereas that of struvite decreased. Initially, both COM and
COD crystals were small. With time, there was a substantial
increase in the size of COM and COD crystals that appeared
aggregated. Urine aspirated at the time of killing contained
both small crystals and large aggregates (Figure 6a and b),
often up to 100 mm in diameter. Some deposits contained
both COM and COD crystals; however, most were comprised
of only COM or COD crystals. Crystal twining was common.
A few spheroidal CaP crystals were seen in the urine from
both the control and treated rats.
Kidneys and crystal deposition
The kidneys of all treated rats were larger than those of the
comparable control rats. The surface of kidneys of some of
the treated rats had a speckled appearance, clearly showing
the presence of crystals inside. Examination of paraffin-
25
20
15
10
5
0
70
60
50
40
30
20
10
LD
H
 re
le
as
e 
(%
)
Baseline Day 7 Day 14 Day 21 Day 28 Day 35 Day 42
*
**
**
*
¥
*
*
¥
¥¥
¥¥
¥
¥
P<0.05 between baseline and HLP
P<0.05 between norm and HLP
P<0.05 between days
Norm HLP All animals
Baseline Day 7 Day 14 Day 21 Day 28 Day 35 Day 42
P<0.05 between baseline vs HLP
P<0.05 between HLP group
P<0.05 between day 42 vs days 14, 21, 28, and 35
Norm HLP All animals
*
¥
¥
Baseline Day 7 Day 14 Day 21 Day 28 Day 35 Day 42
P<0.05 between baseline vs HLP
P<0.05 between HLP group Norm HLP All animals
0
H
yd
ro
ge
n 
pe
ro
xid
e 
(M
)
9
8
7
6
5
4
3
2
1
0
8-
Is
op
ro
st
an
e 
(pg
/m
l)
¥
¥
¥
a b
c
Figure 4 | Urinary excretion of LDH, H2O2, and 8-IP. (a) Urinary excretion of LDH by treated rats was significantly higher than the controls
on all days examined. (b) There was a significant amount of H2O2 in the urine of treated rats. Highest levels were reached on day 21.
(c) Urinary excretion of 8-IP by treated rats increased significantly, reaching highest levels by day 28.
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Figure 5 | Urinary crystals. (a) Spherulitic CaP in the urine of control
rats. (b) COM crystals in the urine of treated rats.
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Figure 6 | Stone-size crystal deposits isolated from the urinary
bladder of treated rats at the time of killing on day 63. (a) A COD
stone demonstrating both crystal growth and aggregation. (b) CaOx
stone containing both mono and dehydrate crystals.
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embedded sections by light microscopy revealed the presence
of birefringent CaOx crystals (Figure 7a and b). Scanning
electron microscopic (SEM) investigations showed that most
crystal deposits consisted mainly of plate-like, rectangular
COM crystals. Some deposits contained both COM and
tetragonal bipyramidal COD crystals. Elemental analysis of
the crystal deposits by energy dispersvie X-ray microanalysis
produced major peak of only Ca, indicating the absence of
CaP crystals (results not shown).
Microscopic analysis of kidneys did not reveal major
differences in the pattern of crystal deposition between rats
treated for 4, 6, or 9 weeks. After 4 weeks, kidneys of
all treated rats (4/4) contained CaOx crystals present in all
sections of the kidneys: cortex, medulla, and papilla. Two rats
demonstrated an interesting pattern of renal crystal distri-
bution with most crystals located in the cortex and outer
medulla (Figure 7a), a few in the inner medulla, and large
deposits were observed on the papillary tip surface (Figure
7b). After 6 weeks, the kidneys of three out of four rats still
contained CaOx crystals in the cortex, medulla, and papilla;
however, in one rat, they were mainly seen in the papilla
encrusting the papillary surface. After 9 weeks, even though
all sections of the kidneys of all treated rats (4/4) contained
some CaOx crystal deposits, they were primarily present in
the renal papillae. Crystal deposits present in the renal
papillae were mostly located in the subepithelial collecting
ducts near the surface in the fornices and on the papillary
tips.
Owing to tissue damage during processing for light
microscopic examination, the precise location of crystals
within various segments of the renal tubules was difficult to
determine. However, careful examination showed that after 4
weeks of treatment, crystals were mostly present in the
tubular lumens of the distal tubules and collecting ducts.
Crystals were also seen in both the thin and the thick limbs of
the loop of Henle. After 6–9 weeks, crystals were also found in
the renal interstitium, particularly of the renal papillae. Most
a
c d
b
Figure 7 | Light micrograph of median section through the kidney
of rat killed after 28 days of consuming HLP. CaOx crystals are
birefringent under polarizing conditions. (a) Birefringent CaOx
crystals are mainly present in the cortex and parts of the outer
medulla. A few crystals are present at the papillary base.
(b) Subsurface birefringent crystals at the papillary tip. Some crystals
are also seen embedded in the pelvic floor. Apparently, a stone was
present at the papillary tip occupying the pelvis all the way to the
pelvic floor. Stone was lost during processing and only the crystals
adherent to the kidney and pelvic floor remained. Area surrounded
by the rectangle is magnified in (c) and (d). (c) White arrow points to
crystals inside a collecting duct. Black arrow shows crystal deposit
most likely in the loop. (d) Crystals are present in the collecting ducts
located under the surface epithelium. White arrow points to a
subepithelial crystal. Tubules are damaged. Papillary surface
epithelium shows focal hyperplasia. Black arrow points to giant
cell formation.
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Figure 8 | SEM analysis of the papillary surfaces of treated rat
kidneys. (a) A small protrusion on the papillary surface. Surface
epithelium is mostly intact. (b) Papillary surface protuberance with
stretched surface epithelium showing development of cracks.
(c) Surface epithelium shows cracks with protruding crystals.
000613
a b
4.0 kv ×2.00k 15.0 m 000625 4.0 kv ×2.50k 12.0 m
Figure 9 | Higher magnifications of the areas in Figure 8.
(a) Development of cracks on the surface. Intact cells show excellent
morphology. (b) Monoclinic COM crystals mixed with cellular debris
are clearly visible.
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tubules containing crystals were dilated and showed destruc-
tion of the lining epithelium. Neighboring tubules appeared
normal with no overt signs of injury. Inflammatory cells
were present in the interstitium adjacent to the large
crystal deposits in the cortex as well as in the papilla (Figure
7c and d).
Crystal deposition in collecting ducts close to the surface
resulted in the development of surface protrusions, which in
some sections appeared to erupt through the urothelium and
form crystalline encrustations on papillary surfaces. SEM
examination of such surfaces showed the protrusions to
range from small bulges with intact surface epithelium to
large eruptions (Figure 8a–c) with protruding CaOx crystals
and stretched surface epithelium with localized areas of cell
separations (Figure 9a). Large eruptions showed remnants
of epithelium at the edges and as cell debris mingled with
the exposed crystals (Figure 9b).
Immunohistochemical analysis of the kidneys
Staining of tubular epithelial cells for proliferating cell
nuclear antigen (PCNA) was increased in kidneys of treated
rats (Figure 10a). Increased staining was detected in tubules
containing crystal as well as in some with no crystal deposits.
Crystal deposits were surrounded by ED-1-positive cellular
infiltrates in the adjacent interstitium (Figure 10b).
CD44 was poorly expressed in the normal rat kidneys and
highly expressed in renal tubules of treated rats (Figure 11a),
particularly segments with crystal deposits. Expression of
OPN was also poor in the normal renal tubules, but increased
in tubules of the treated rats (Figure 11b). Crystal deposits
were heavily stained. Epithelial staining, however, was diffuse
and not limited to only the crystal-associated sections of the
tubules.
DISCUSSION
This report describes a rat model of CaOx nephrolithiasis
wherein excretion of Ox was increased by the administration
of HLP.28 HLP has been used successfully to induce both
hyperoxaluria and CaOx crystal deposition in pigs25 and the
GH rats.26 In our rat model, as well as in the pigs, HLP was
administered with the food, whereas in GH rats HLP was
provided in the drinking water. As we have shown, HLP
administration through diet not only increased urinary Ox,
but after 4 weeks it also produced CaOx crystal deposits in
the kidneys in normal male Sprague–Dawley rats. In an
earlier study, intraperitoneal dispensation of HLP to male
rats also resulted in crystal deposition in the kidneys.29
Reasons for these discrepancies are not clear, but the amount
of lithogen given and the mode of administration may play a
role. Differences in the absorption and subsequent metabo-
lism of HLP are also likely to be involved.
It should also be pointed out that administration of
various amounts of HLP resulted in the development of
similar levels of hyperoxaluria in both the GH rats and pigs.
Crystal deposits in the GH rat kidneys were restricted to the
urinary space, whereas those in the kidneys of pigs on HLP
were seen in the renal tubules encrusting the renal papillae. In
our study, CaOx crystals were seen in the renal tubules of
both the cortex and medulla, including the ducts of Bellini
of the renal papillae.30 These results of HLP-induced CaOx
nephrolithiasis in normal rats and pigs are similar to EG-
induced CaOx nephrolithiasis in the rats, where CaOx
crystals are seen in all parts of the kidneys: cortex, medulla,
and papilla. Perhaps, the urine of GH rats becomes super-
saturated with respect to CaOx only after reaching the
urinary space, whereas in normal rats urinary supersatura-
tion reaches the crystallization level much earlier in the
nephron.
CaOx crystal deposits were seen in all parts of the kidney
as well as in all segments of the renal tubules. Notably, crystal
deposition was observed in the outer medulla at cortico-
medullary junction and in the renal fornices and papillary
tips. These sites are characterized by a change in luminal
diameter of the renal tubules and urine is moving from wider
to the narrower space.5,30
HLP-induced hyperoxaluria and renal CaOx crystal depo-
sition was associated with renal injury. There was a significant
increase in urinary excretion of LDH, a marker of membrane
permeability and damage. This increase was evident on day 7,
much earlier than crystal deposition, indicating that by
that day Ox levels reached a concentration high enough to
injure the kidneys. By day 7, urinary excretion of H2O2 and
8-IP also increased significantly, indicating the overproduc-
tion of reactive oxygen species and the development of
a b
Figure 10 | Immunohistochemical localization of PCNA and ED-1
in the kidneys of treated rats. Crystals have dropped out of the
paraffin sections during staining. (a) A large number of epithelial cells
stain positive for PCNA. (b) A number of ED-1-positive cells are
present in the renal interstitium.
a b
Figure 11 | Immunohistochemical localization of CD44 and OPN
in the kidneys of treated rats. (a) CD44 staining is limited to the
crystal-containing tubules and is more pronounced on baso-lateral
aspects of the epithelial cells. (b) OPN staining is seen in many
crystal-containing tubules. The luminal contents as well as epithelial
cells are positively stained.
Kidney International (2006) 70, 914–923 919
SR Khan et al.: Hyperoxaluria and calcium oxalate nephrolithiasis o r i g i n a l a r t i c l e
oxidative stress.31 Results of other studies of hyperoxaluria-
induced CaOx nephrolithiasis in rats have confirmed the
production of reactive oxygen species and changes in the
renal cellular endogenous antioxidant defenses in association
with renal injury.7,8,19,32 Recently obtained human data
are also suggestive of the development of oxidative stress
in kidney stone patients.33,34 Earlier studies have shown the
presence of renal injury in kidneys of idiopathic stone
formers.35
Morphological changes associated with CaOx crystal
deposition in kidneys of the HLP-administered rats included
tubular obstruction, focal dilatation, and loss of tubular
epithelium. In addition, a number of tubular epithelial cells
stained positive for PCNA, indicating cellular regeneration
following tubular epithelial loss. These changes were mostly
limited to tubular sections that contained the crystals and are
similar to renal changes seen in other models of hyper-
oxaluric CaOx nephrolithiasis.
Crystal retention within the renal tubules is promoted by
renal epithelial injury, which exposes a variety of crystal
adhesion molecules on epithelial surfaces, including CD44
and its ligands OPN and hyaluronic acid.36–38 OPN is
upregulated in EG-induced CaOx nephrolithiasis showing
highest expression in crystal-containing tubules. Renal
epithelial cells exposed in vitro to both high levels of Ox
and CaOx crystals produce copious amounts of OPN.39 A
reduction in OPN production leads to reduced crystal
attachment.40 OPN immunostaining is also increased in
urothelium surrounding CaOx crystal deposits in renal fornix
of the GH rats.41 Thus, the increased levels of CD44 and
OPN in epithelial cells of crystal-containing tubules in HLP-
induced CaOx nephrolithiasis may also be similarly involved
in crystal retention.
CaOx crystal deposition in kidneys of hyperoxaluric rats is
commonly associated with inflammation in which neighbor-
ing interstitium becomes occupied with multinucleated giant
cells and macrophages that stain positive for ED-1 anti-
gen.42,43 Human kidneys with acute or chronic oxalosis also
show inflammation and fibrosis.44–46 The presence of ED-1-
positive cells in the renal interstitium near HLP-induced
CaOx crystal deposits provides further proof for the
inflammation-inducing activity of such crystals. We have
hypothesized that macrophages are recruited to the sites of
crystal deposition to reduce the renal crystal burden and thus
provide an early defense against stone formation.47 Other
studies have provided evidence that, at least in animal models,
anti-inflammatory substances such as angiotensin-converting
enzyme inhibitors and angiotensin receptor antagonists
reduce the deposition of CaOx crystals in the kidneys.16,48
In our study, crystals were mostly present in the renal
tubules, and in the papillae, many were lodged in sub-
epithelially located collecting ducts. Large deposits appeared
to have burst open and showed protruding CaOx crystals.
Similar crystal deposits have been seen in other rat models of
hyperoxaluric CaOx nephrolithiasis.5 Encrustations seen in
hyperoxaluric pigs appear to be similarly formed. These
intratubular deposits are reminiscent of Randall’s Type 2
plaques.49,50
Randall51,52 suggested that kidney stones develop on two
types of pre-calculus lesions. The more common lesion
consisting of interstitial subepithelial deposits of CaP and
calcium carbonate on the pelvic aspect of the papilla was
called Type 1 lesion. The infrequent lesion formed by CaP
crystal deposition in the ducts of Bellini was termed Type 2
lesion. He suggested that Type 1 lesion arose from pathologic
condition of the papilla, whereas Type 2 developed from
excessive supersaturation and necrosis of the tubular
epithelial cells. It has been suggested that plaques lose their
epithelial covering, become exposed to the pelvic urine, and
develop into stone niduses.
Various studies have confirmed the formation of a variety
of stones including CaP, CaOx, uric acid, and cystine on
Type 1 lesions.51–55 Renal interstitium and epithelial cells of
idiopathic stone formers remain normal and crystal matrix
is positive for OPN. Brushite stones and CaOx stones
developed after intestinal bypass surgery are formed in
association with Type 2 lesions consisting of intraluminal
CaP deposits. Renal tubules appear damaged and interstitium
contains inflammatory cells. In a case where papillary tissue
was removed from a patient with bilateral renal lithiasis,
we found a CaOx stone lodged in a duct of Bellini (554).
Biological apatite crystals were found in the nearby inter-
stitium. Tubular cells were damaged and interstitium
appeared fibrotic
Conclusions
It has been suggested that EG is not a useful agent to induce
CaOx nephrolithiasis in animal models because it can
produce severe life-threatening metabolic acidosis, has multi-
organ toxicity, and its metabolites glycoaldehyde and
glyoxylate are also highly toxic. HLP, a common amino acid,
is considered a better alternative but so far in the normal
male rats it has produced only hyperoxaluria. HLP admin-
istration to GH rats produced CaOx crystals in the kidneys,
but they were limited to the urinary space. Results of our
study show that renal and urinary changes seen during the
development of CaOx nephrolithiasis in HLP-treated rats are
similar to those seen in rats provided with EG. Porcine model
of CaOx nephrolithiasis showed similar morphological
changes in the kidneys. Other rat models of CaOx nephro-
lithiasis, regardless of the type of hyperoxaluria-inducing
agent and means of delivery, have shown similar renal injury
in the presence of hyperoxaluria and CaOx crystal deposition
(Table 2). Thus, renal pathology seen in animals with
experimental CaOx nephrolithiasis is perhaps a result of
cellular exposure to high Ox and CaOx crystals because the
damage was mostly focal and seen in the tubules that were
full of CaOx crystals.
Crystal deposits seen in the renal papillae of rats with
experimentally induced hyperoxaluria are similar to Randall’s
Type 2 lesions in that both are intratubular, plug the
collecting ducts, damage the tubular epithelium, and induce
920 Kidney International (2006) 70, 914–923
o r i g i n a l a r t i c l e SR Khan et al.: Hyperoxaluria and calcium oxalate nephrolithiasis
interstitial inflammation. Eruption of crystals deposited in
the subepithelial collecting ducts leads to the formation of a
stone nidus. The difference between human and rat Type 2
lesions is that in the humans, lesions are generally apatite,
but a human case with intratubular CaOx crystals has been
reported.
MATERIALS AND METHODS
Animal protocol
Male Sprague–Dawley rats (120–130 g) were purchased from Harlan.
After 1 week of acclimatization to our animal facilities, they were
divided into two groups, control and experimental. Both had easy
access to food and water, and their consumption was recorded daily.
Food was ground, moistened with water, and formed into small
balls, which were individually weighed. Control rats received normal
rat chow, whereas experimental animals were given chow mixed
with 5% HLP (weight/weight HLP/chow) purchased from ICN
Biochemicals (Aurora, OH, USA). Food and water consumption
were regularly monitored. Rats were weighed weekly to check their
growth.
Urine was collected daily for determination of crystalluria and
weekly for the analyses of urinary ions and markers of cell injury
and lipid peroxidation. Four control rats and four experimental rats
were killed after 4, 6, and 9 weeks. Their bladder urine was aspirated
and examined for the presence of crystals. Their kidneys were
processed for localization of crystals and various other morpho-
logical analyses.
Urine collection and analysis
Once a week, 24-h urine collection was made with 0.02% sodium
azide to prevent bacterial growth. Rats were placed in metabolic
cages for the collection of urine. After determining urinary volume
and pH, urine was aliquoted for various assays.
For the determination of Ox, an aliquot of 24 h urine samples
from control and experimental subjects was acidified by the addition
of 1 M HCl (20:1 dilution) and kept frozen in closed vials until
analyzed. Just before analysis, the samples were thawed and brought
to room temperature, mixed, and Ox determinations were carried
out in triplicate. Analyses were performed using a Dionex DX100
gradient ion chromatography system equipped with a 0.4 25 cm
AS10A anion exchange analytical column containing an AG10A
guard column. Urinary Ca and creatinine were also determined
using methods described in our previous studies. Serum creatinine
was measured at the time of killing.
Centrifuged urine supernatants were used to determine LDH.
LDH was analyzed on the spectrophotometer by measuring the
rate of decrease of absorbance of nicotinamide adenine dinucleo-
tide (reduced form) at 340 nm using pyruvate as the substrate. To
investigate the development of oxidative stress, we determined
urinary excretion of H2O2, a reactive oxygen species, and 8-IP, a
product of lipid peroxidation. H2O2 quantification was carried out
Table 2 | CaOx nephrolithiasis in rats
Induction technique Crystal deposition Renal and urinary changes Strengths
EG in drinking
water4,5,11–17
Intraluminal in renal tubules of both
cortex and medulla; crystals deposit in
association with cellular degradation
products; plaques, and stones at
papillary tips
Necrotic and apoptotic renal injury;
interstitail inflammation; increased
synthesis and urinary excretion of OPN,
bikunin, MCP-1, a-1-microglobulin,
hyperoxaluria, enzymuria,
membranuria, and CaOx crystalluria
Easy to induce consistent
hyperoxaluria, crystalluria, and CaOx
nephrolithiasis
HLP in drinking
water9,41
No crystals in the renal tubules; crystal
aggregates in the renal fornices and
pelvis
Kidneys appear normal; hyperoxaluria,
enzymuria, and CaOx crystalluria;
increased synthesis of OPN by papillary
surface epithelial cells
Simple; more physiological than the
administration of EG or some other Ox
precursors
HLP mixed with food Intraluminal in renal tubules of both
cortex and medulla; plaques, and
stones at papillary tips
Hyperoxaluria and CaOx crystalluria;
signs of renal injury and inflammation
in association with the crystals
Same as above
Implantation of
osmotic mini-pumps
filled with Ox56
Intraluminal in renal tubules of both
cortex and medulla
Hyperoxaluria, CaOx crystalluria, and
upregulation of TNF receptor kidney
injury marker and OPN
Reliable and consistent hyperoxaluria
and CaOx nephrolithiasis
Vitamin B-6-deficient
diet57
CaOx crystals intraluminal in tubules of
medulla; plaques on papillary tips;
stones in renal fornices, pelvis, ureters,
and bladder
Hyperoxaluria, hypercalcalciuria,
enzymuria, hypocitraturia, and CaOx
crystalluria
Glycolic acid in diet58 CaOx crystals in the tubules of renal
cortex and medulla; stones in renal
pelvis
Hyperoxaluria
Ileal resection and
feeding of Ox59
CaOx mixed with CaP and Ca carbonate
crystals; intraluminal in both cortex and
medulla; interstitial in the papilla;
plaques on papillary surface
Tubular obstruction and interstitial
inflammation; hyperoxaluria and
hypocitraturia
Models nephrolithiasis after ileal
resection or bypass surgery
Intraperitoneal
administration of Ox
or HLP29,50
CaOx crystal deposition in all sections
of the kidneys, initially intraluminal and
then also seen in the interstitium;
papillary plaques of CaOx
Tubular obstruction and dilatation;
interstitial inflammation; crystal
formation in association with
membrane fragments; hyperoxaluria,
CaOx crystalluria, enzymuria, and
membranuria
Easy to accomplish crystal deposition
in the kidneys for investigating crystal
cell interactions
Ca, calcium; CaOx, calcium oxalate; CaP, calcium phosphate; EG, ethylene glycol; HLP, hydroxy-L-proline; MCP, monocyte chemoattractant protein; OPN, osteopontin;
Ox, oxalate; TNF, tumor necrosis factor.
Kidney International (2006) 70, 914–923 921
SR Khan et al.: Hyperoxaluria and calcium oxalate nephrolithiasis o r i g i n a l a r t i c l e
using a colormetric assay obtained from Pierce (PeroXoquant
Quantitative Peroxide Assay Kit, Pierce Biotechnology Inc., Rock-
ford, IL, USA: catalogue no. 23280). Determination of urinary
isoprostane was carried out using a kit from Oxford Biomedical
Research (Urinary Isoprostane, Cayman Chemical Company, Ann
Arbor, MI, USA: catalogue no. EA85).
Urine was examined by light microscopy to analyze crystalluria.
Selected urine samples and bladder urine collected at the time of
killing were filtered through 0.2 mm nucleopore filter for examina-
tion and analysis,27 with an SEM and energy dispersive X-ray
microanalysis.
Kidney tissue processing
Four rats from the normal control group and four from the
experimental group were killed after 4, 6, and 9 weeks. Details of
tissue preparation for light and SEM analyses are described in our
earlier publications.8,9,11–14 The presence of CaOx crystal was scored
on a basis of 0–4þ .
Immunohistochemistry
To confirm that HLP-induced hyperoxaluria follows similar patterns
and produces similar outcomes, OPN and CD44 were localized
immunohistochemically using specific antibodies. Cell proliferation
was determined by immunohistochemical staining for PCNA.
Migration of M/M into the interstitium was determined by
immunohistochemical staining with ED-1 antibodies.
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